Street sellers and private physicians fuel antibiotic overuse
Limited access to medical professionals and irresponsible prescribing practices are contributing to antimicrobial resistance in low-resource settings.
More from Nature Outlook: Antimicrobial resistance
Pathogens are becoming resistant to antibiotics. Scientists and physicians are working to slow the process and replenish the medicinal armoury.
Old antibiotics are being revived to fight new threats
The last antimicrobial peptide was developed decades ago. Now, drug-resistant bacteria are forcing scientists to take a fresh look at this class of antibiotic.
Economic reform can save antibiotic innovation
Governments must create meaningful incentives for biopharmaceutical companies to develop antimicrobial products.
The hunt for the next antibiotics
To battle antibiotic resistance researchers are leaving no stone unturned, looking at folk traditions and harnessing AI to find new antibiotics.
Are non-antibiotic drugs contributing to antimicrobial resistance?
Plans to address drug resistance typically focus on the use of antibiotics, but there are signs that compounds with incidental antibacterial effects might be part of the problem, too.
Why farm workers need protection from antimicrobial resistance
Antibiotic use in agriculture threatens the health of workers and their communities, but there are potential solutions.
The fightback against antimicrobial resistance starts at home
Microbiologist Alexander Fleming’s 80-year-old advice is still key to protecting the efficacy of antibiotics.
Antibiotics look like any other drugs — and that’s a problem
Medical microbiologist Heiman Wertheim explains why the physical appearance and labelling of antibiotics matter when trying to limit resistance.
Antifungal resistance is growing – will new treatments turn the tables?
Trials of drugs to fight deadly resistant infections are advancing, but they might fall victim to overuse of agricultural fungicides just like their predecessors.
Six key developments in the fight against antimicrobial resistance
Antibiotics designed by artificial intelligence, immunotherapy for resistant infections and other highlights from studies and trials.